Today: 8 June 2026
Browse Category

NYSE:GLD 25 December 2025 - 12 January 2026

Gold price breaks $4,600 record; GLD ETF and gold stocks jump on Powell probe

Gold price breaks $4,600 record; GLD ETF and gold stocks jump on Powell probe

Gold prices hit a record $4,627.27 an ounce Monday, lifting SPDR Gold Shares 2.4% to $424.45 and sparking gains across gold-linked stocks. The dollar index slipped 0.2% as investors eyed Federal Reserve policy and the Powell investigation. CME FedWatch put the odds of steady rates in January at 95%. U.S. consumer price data is due Tuesday, with the Fed meeting Jan. 27-28.
Gold price smashes $4,600 record and gold stocks jump — here’s what traders watch next

Gold price smashes $4,600 record and gold stocks jump — here’s what traders watch next

Newmont jumped nearly 4% Monday as gold hit a record above $4,600 an ounce amid political unrest and a standoff over Fed Chair Jerome Powell. The dollar index fell 0.4% to 98.84 after Powell disclosed subpoenas tied to his testimony. Gold futures rose 2.1% to $4,596.70, while the SPDR Gold Shares ETF gained 2.4%. Investors are watching U.S. CPI data and the Fed meeting on Jan. 27-28.
Silver price hits record highs; SLV stock jumps in premarket as Fed probe rattles markets

Silver price hits record highs; SLV stock jumps in premarket as Fed probe rattles markets

Spot silver surged 5.5% to $84.32 an ounce Monday, hitting a record high as SLV jumped 3.8% in premarket trading. The rally followed threats from the Trump administration to indict Fed Chair Jerome Powell, fueling safe-haven demand. Wall Street futures fell 0.7% amid policy uncertainty. Traders await Tuesday’s U.S. CPI report for signals on rates and the dollar.
Gold price stock rally: GLD, Newmont climb after soft U.S. jobs data lifts bullion

Gold price stock rally: GLD, Newmont climb after soft U.S. jobs data lifts bullion

Spot gold rose 0.6% to $4,502.98 an ounce Friday after U.S. payrolls data missed forecasts, pushing bullion near record highs. SPDR Gold Shares gained 0.3%, while Newmont, Agnico Eagle, and Franco-Nevada advanced. Investors await U.S. Supreme Court tariff rulings Jan. 14 and the Fed’s Jan. 27-28 meeting for further policy signals.
Gold price slips ahead of U.S. jobs data as Newmont stock and GLD track bullion

Gold price slips ahead of U.S. jobs data as Newmont stock and GLD track bullion

Spot gold dropped 0.6% to $4,427.48 an ounce Thursday as funds positioned ahead of the Bloomberg Commodity Index rebalancing and the dollar strengthened. Newmont shares slipped 1.1% premarket, while SPDR Gold Shares lost 1%. HSBC projected gold could reach $5,000 in early 2026 but warned of a possible correction if Fed rate cuts stall.
Gold price rally lifts GLD stock in premarket as Fed cut bets grow, Venezuela in focus

Gold price rally lifts GLD stock in premarket as Fed cut bets grow, Venezuela in focus

SPDR Gold Shares (GLD) jumped $10.41, or 2.6%, to $408.76 in U.S. premarket trading Tuesday as spot gold hovered near highs after the U.S. captured Venezuelan President Nicolas Maduro. Traders cited safe-haven demand and rising bets on Federal Reserve rate cuts. The ISM manufacturing PMI fell to 47.9 in December, its lowest since October 2024. Other gold funds and miners also advanced before the bell.
Gold price today rebounds near $4,370 as GLD ETF and gold stocks track bullion higher

Gold price today rebounds near $4,370 as GLD ETF and gold stocks track bullion higher

Spot gold rose 1.7% to $4,387.58 an ounce in New York morning trade Friday, after hitting a record $4,549.71 on Dec. 26 and then sliding to a two-week low Wednesday. Dealers in India and China returned to charging premiums as physical demand picked up. The U.S. dollar started 2026 weaker after its sharpest annual drop since 2017. CME Group raised margin requirements for precious metals futures after recent volatility.
Gold price stock today: GLD jumps nearly 2% in premarket as gold rebounds toward record highs

Gold price stock today: GLD jumps nearly 2% in premarket as gold rebounds toward record highs

SPDR Gold Shares (GLD) rose 1.9% to $404.00 in premarket trading, tracking a nearly 2% jump in spot gold to $4,397.66 an ounce. Gold hit a record $4,549.71 on Dec. 26 and gained 64% in 2025, its strongest year since 1979. Newmont climbed 2.8% premarket as gold and silver advanced. Investors await key U.S. jobs and inflation data next week for signals on Federal Reserve policy.
Gold price today slips as CME margin hike spurs profit-taking — GLD and gold stocks edge lower

Gold price today slips as CME margin hike spurs profit-taking — GLD and gold stocks edge lower

Spot gold fell 0.6% to $4,321.63 an ounce by midday Wednesday, while February U.S. gold futures dropped 1.1% to $4,335.40. SPDR Gold Shares and VanEck Gold Miners ETF each slipped 0.4%. Traders cited year-end profit-taking after CME raised margin requirements on precious-metals futures. Newmont lost 1.1% and Agnico Eagle Mines declined 0.6%.
31 December 2025
Gold price stock today: GLD steadies after wild swing as Fed minutes, margin hike keep traders cautious

Gold price stock today: GLD steadies after wild swing as Fed minutes, margin hike keep traders cautious

Gold rebounded 0.8% to $4,364.70 an ounce Tuesday after plunging 4.47% Monday, as thin year-end trading fueled volatility. The SPDR Gold Shares ETF edged up 0.1%, and gold miners steadied. CME Group raised margin requirements for precious-metals futures. Investors await Wednesday’s U.S. jobless claims and the final trading session of 2025.
Silver price rebounds after margin shock; SLV jumps as China export list and Fed minutes loom

Silver price rebounds after margin shock; SLV jumps as China export list and Fed minutes loom

Spot silver jumped 5.7% to $76.34 an ounce Tuesday after a 9.5% plunge Monday, with iShares Silver Trust up 3.5% in early U.S. trading. CME Group raised initial margin requirements on COMEX silver futures by 13.6% to $25,000 per contract. China authorized 44 firms to export silver in 2026–27. Traders await Fed minutes and monitor thin year-end liquidity.
Silver price today: SLV sinks after-hours as margin hike fuels sharp metal selloff

Silver price today: SLV sinks after-hours as margin hike fuels sharp metal selloff

iShares Silver Trust (SLV) fell 7.1% to $66.01 and abrdn Physical Silver Shares ETF (SIVR) dropped 7.2% to $69.33 in after-hours trading Monday. Spot silver slid about 9% to $72.11 an ounce after hitting $83.99 earlier. CME Group raised margin requirements on silver futures after the close. Silver miners and gold proxies also declined sharply.
Silver Tops $75, Gold Breaks $4,530 and Platinum Hits Records as Precious Metals ETFs Surge Into Year-End 2025

Silver Tops $75, Gold Breaks $4,530 and Platinum Hits Records as Precious Metals ETFs Surge Into Year-End 2025

Silver surged above $75 an ounce for the first time on December 26, with gold and platinum also hitting new records in thin post-holiday trading. Spot gold reached an intraday high near $4,530, while platinum touched $2,448. Silver is up about 158% for the year, outpacing gold’s 72% gain. ETF volumes in SLV, GLD, and PPLT spiked as investors chased the rally.
Gold Price Today (December 25, 2025): Spot Gold Pares Gains Near $4,475 After Record $4,525 Breakout

Gold Price Today (December 25, 2025): Spot Gold Pares Gains Near $4,475 After Record $4,525 Breakout

Spot gold slipped to around $4,479 per ounce on December 25 after hitting a record $4,525.18, as traders locked in profits in thin holiday trading. U.S. gold futures settled near $4,503. Major exchanges operated with limited staff or closed, amplifying price swings. Gold remains near record highs, supported by rate-cut expectations and a weaker U.S. dollar.
25 December 2025

Stock Market Today

  • Stock Market Update: Dow Expected to Weaken, Nasdaq to Gain After Sharp Dip; Oil Prices Surge Amid Middle East Conflict
    June 8, 2026, 9:06 AM EDT. The Dow Jones Industrial Average is set to weaken while the Nasdaq Composite is poised for gains after the S&P 500 experienced its worst day since October. This downturn follows renewed violence in the Middle East, with Iran striking Israel, escalating geopolitical tensions. Oil prices jumped significantly, reflecting concerns over supply disruptions linked to the conflict. Investors remain cautious as markets digest the impact of escalating regional instability on global economic outlooks.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Go toTop